| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,233 |
29,972 |
$1.82M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,204 |
16,930 |
$1.28M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18,223 |
18,134 |
$1.13M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
29,085 |
26,333 |
$758K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,551 |
3,533 |
$310K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,356 |
6,964 |
$206K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,026 |
7,632 |
$152K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,845 |
8,648 |
$81K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,271 |
8,686 |
$74K |
| 71046 |
Radiologic examination, chest; 2 views |
3,834 |
3,675 |
$57K |
| 99000 |
|
14,641 |
13,356 |
$52K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,211 |
1,210 |
$51K |
| 81025 |
|
6,225 |
5,958 |
$32K |
| 81002 |
|
8,611 |
8,248 |
$19K |
| 99215 |
Prolong outpt/office vis |
158 |
157 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,071 |
2,960 |
$15K |
| 99058 |
|
215 |
195 |
$13K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
33 |
33 |
$13K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
33 |
33 |
$10K |
| 73130 |
|
554 |
524 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,313 |
4,116 |
$8K |
| 73630 |
|
400 |
385 |
$6K |
| 16020 |
|
171 |
168 |
$6K |
| 87807 |
|
826 |
811 |
$5K |
| 99001 |
|
1,991 |
1,790 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,656 |
1,613 |
$4K |
| 73562 |
|
203 |
187 |
$4K |
| 72100 |
|
233 |
233 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,812 |
2,733 |
$4K |
| 36010 |
|
22 |
22 |
$4K |
| 74240 |
|
59 |
59 |
$4K |
| 69210 |
|
148 |
143 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
739 |
720 |
$3K |
| 29540 |
|
299 |
297 |
$3K |
| 73610 |
|
176 |
164 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,821 |
1,743 |
$3K |
| 73030 |
|
125 |
119 |
$2K |
| 74019 |
|
142 |
138 |
$2K |
| 99205 |
Prolong outpt/office vis |
16 |
16 |
$2K |
| 93000 |
|
217 |
216 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
62 |
62 |
$962.13 |
| 86308 |
|
254 |
252 |
$839.77 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
94 |
94 |
$806.82 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
27 |
$782.87 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
34 |
34 |
$600.30 |
| 99406 |
|
133 |
121 |
$552.36 |
| 90715 |
|
24 |
24 |
$524.21 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
95 |
92 |
$427.21 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
93 |
91 |
$380.83 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
461 |
444 |
$345.65 |
| 90714 |
|
25 |
25 |
$317.81 |
| 90756 |
|
17 |
17 |
$266.60 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
1,827 |
1,742 |
$243.57 |
| 72070 |
|
14 |
13 |
$235.32 |
| 73560 |
|
19 |
17 |
$215.87 |
| 72040 |
|
14 |
14 |
$212.13 |
| 86769 |
|
12 |
12 |
$140.00 |
| 73600 |
|
15 |
14 |
$135.87 |
| 29260 |
|
14 |
12 |
$129.72 |
| 82962 |
|
57 |
55 |
$121.20 |
| 36410 |
|
319 |
307 |
$111.31 |
| 87252 |
|
13 |
13 |
$60.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
324 |
322 |
$32.69 |
| A6451 |
Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard |
124 |
122 |
$24.51 |
| Q0247 |
Injection, sotrovimab, 500 mg |
19 |
19 |
$0.18 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
44 |
40 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
17 |
17 |
$0.00 |
| 97010 |
|
12 |
12 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
30 |
29 |
$0.00 |
| S9083 |
Global fee urgent care centers |
40 |
40 |
$0.00 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
188 |
185 |
$0.00 |
| 99051 |
|
367 |
362 |
$0.00 |
| 99072 |
|
657 |
633 |
$0.00 |